Blog
What to know and what to do if you are not entitled
Jun
Obesity remains one The most smoking and preventing health challenges of our time. Great Britain It is one of many countries undoubtedly struggling.
Affects almost every organs in the body, contributing to cardiovascular diseases such as coronary artery disease; musculoskeletal problems such as osteoarthritis and gout; and even development Some cancerIn this breast, uterus and colon. Its impact on mental health is also significant.
A few years ago, drugs for losing weight for injection came into the clinical apply and quickly drew the attention of the public for their ability to promote rapid loss of fat. Ozmpic It is available at NHS, but only for type 2 diabetes management. Wegova He is authorized to lose weight and reduce cardiovascular risk and is also available at NHS, although access is currently confined to specialized weight management services.
Now a recent option has appeared: Mounjarowhich is approved for both type 2 diabetes and weight loss. This double drug is now available at NHS, offering another potential tool in the fight against obesity.
The demand is It is expected to be high. However, initially access will be confined, with strict NHS prescriptions eligibility.
Get your messages from real experts, straight to the inbox. Sign up to our daily newsletter to receive the latest reports from news and research in Great Britain, from politics and business to art and science.
What is Mounjaro?
Mounjaro (Tirrzepatide) are once weekly injection drugs designed to control blood sugar levels. It works by increasing the secretion and effects of insulin, improving glycemic control in people with Type 2 diabetes. It also slows down the gastric emptying – a process in which food leaves the stomach – and increases the sense of fullness through the brain. This combined effect reduces appetite and helps support weight loss.
Compared to similar drugs, such as Ozmpic and Wegova (both brands to semaglutide), Clinical examinations He stated that Mounjaro was more effective, and some participants lose to 20% of body weight in 72 weeks.
Read more: The best exercises to do while taking slimming drugs
Who qualifies for Mounjaro on NHS?
NHS has introduced specific criteria To treat patients in need the most priority.
First of all, patients need BMI of 40 or more (classified as morbid obesity). People from some ethnic origin, such as the South Asia community, can qualify for a lower BMI Due to higher clinical risk health conditions.
Secondly, at least four health conditions related to obesity, including type 2 diabetes, hypertension (high blood pressure), dyslipidemia (abnormal cholesterol or triglyceride), cardiovascular and heart apnea disease should be diagnosed at least. (Some of these conditions often occur together; for example, high blood pressure and cholesterol.)
Patients are encouraged to check Bmia And confirm their diagnosis before contacting the GP. This helps to ensure effective apply of business and discussions remain concentrated.
Although the current criteria are strict, there is optimism that in the coming years eligibility will expand to cover people with lower BMI and less co -existing.
Does not qualify? Do not despair
NHS still offers Comprehensive weight loss programTo the layer according to BMI and previous attempts to lose weight. Do not underestimate the values of group programs or social referrals-when a health care worker refers to the patient to the health community for further care or support-which many can be obtained through a family doctor.
These services such as NHS DIGITAL WAMPER PROGRAMSupport both people and family and can be very effective in indefinite fat loss.
GPS can also manage patients with online courses and structured exercise programs. Lifestyle interventions, including increased physical activity and healthier food, remain the cornerstone of obesity treatment and are of key importance for long -term success, even when drugs are used.
Read more: From diet to medicines: what really works for long -term weight loss
You can take into account the interventions of a higher level if your lifestyle changes are promoted or if the patient has significant co -existing coexisting. At this point, drugs such as Mounjaro or private prescriptions can become crucial – although the cost of the latter may be a limiting factor for some.
Other treatments include OrlistatA drug that reduces fat absorption in the intestines. This may be effective for some, but often causes Unpleasant side effectssuch as fatty stools and nervousness of the digestive tract
Stomach band or surgery It can also result in significant, indefinite weight loss, but they are associated with risk, they can lead to surgical complicationsand recovery can be demanding
It is also crucial to recognize that drugs such as Mounjaro are not suitable for everyone. Can cause side effects Significant enough for people to stop using them, and in some cases they may not work at all.
In this recent era faster, assisted drug loss, we must remember that long -term change is more than quick corrections. Sustainable success results from consistent effort, readiness to change and methods that are both practical and hard-wearing.
Drugs can support, sometimes dramatically, but they are not the only answer. Return to the basics, with adapted support and realistic goals, remains as crucial as always.
Regardless of whether you qualify for Mounjaro, try lifestyle changes or study other options, remember: travel to better health is personal, gradual and worth.
